U.S. market Closed. Opens in 2 days 3 hours 3 minutes

VRTX | Vertex Pharmaceuticals Incorporated Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for VRTX we got that it has average fundamentals where Valuation is considered to be slightly overvalued, Profitability is unacceptably poor, Growth is good and Health is strong.

Valuation (43%)

Company Industry
P/E Ratio (TTM) -247.81 -23.41
PEG Ratio (TTM) 2.21 15.22
P/S Ratio (TTM) 11.76 50.19
P/B Ratio (TTM) 8.22 18.75
P/FCF Ratio (TTM) -85.15 -3.82
Price to 5YR AVG Earnings Ratio 46.00 -3.63
Price to 5YR AVG FCF Ratio 43.05 -9.39

Profitability (25%)

Company Industry
ROA (TTM) -2.43% -5.51%
ROE (TTM) -2.91% 15.68%
Net Profit Margin (TTM) -4.75% -2,035.83%
ROIC 5YR AVG 65.66% 14.56%

Growth (68%)

4QTR AVG 3YR AVG 5YR AVG
EPS -101.69% 23.51% 24.31%
Revenue 1.44% 35.91% 27.16%
Net Income -101.67% 24.31% 24.74%
Cash Flow -0.01% 37.37% 30.80%

Health (67%)

Company Industry
Current Ratio (TTM) 2.52 6.23
Quick Ratio (TTM) 2.26 5.95
D/E Ratio (TTM) 0.06 -15.66
Interest Coverage (TTM) -9.38 -1.78
Piotroski F-Score 3 5
Altman Z-Score 15.00 14.20
LTL to 5YR AVG FCF 0.26 0.17
Shares Outstanding Growth 5YR AVG 0.27% 125.48%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙